Mayo Clinic
Acute Care Hospitals · Voluntary non-profit - Private
4500 San PAblo Rd
Jacksonville, FL 32224
- Emergency services
- Medicare overall rating: 5 of 5 stars
At a glance
- Clinicians who list this hospital
- 1,555
- Physicians (MD and DO)
- 986
- Residents and fellows in training (full-time equivalents, fiscal year 2024)
- 211
- Medical groups
- 15+
Quality and patient experience
- Medicare overall rating (of 5)
- 5
- Patient survey rating (of 5)
- 4
- Patients who would definitely recommend it (national average 71%)
- 89%
Compared with the national rate
| Measures | Better | Same | Worse |
|---|---|---|---|
| Deaths after treatment | 6 | 2 | 0 |
| Safety of care (infections, complications) | 4 | 3 | 0 |
| Readmissions and return visits | 1 | 9 | 1 |
Number of Medicare quality measures where this hospital’s rate is statistically better than, the same as (no different from), or worse than the national rate.
What patients said
- Doctors communicated well 4 of 5 stars
- Nurses communicated well 4 of 5 stars
- Explained medicines 4 of 5 stars
- Discharge information 4 of 5 stars
- Clean 4 of 5 stars
- Quiet at night 4 of 5 stars
From 1,683 patient surveys (HCAHPS), period ending 09/30/2025.
Source: CMS Care Compare (Hospital General Information; Patient survey HCAHPS). Ratings describe the hospital overall, not individual doctors.
Physicians by specialty
- Radiology 105
- Cardiology 61
- Internal Medicine 58
- Hospitalist 56
- Gastroenterology 54
- Anesthesiology 53
- Neurology 50
- Family Medicine 49
- Hematology & Oncology 41
- Pulmonology 36
- Pathology 34
- Emergency Medicine 32
- Critical Care Medicine 27
- Nephrology (Kidney) 21
- Urology 20
- Interventional Radiology 19
- Neurosurgery 18
- General Surgery 18
- Dermatology 18
- Radiation Oncology 16
- Orthopedic Surgery 15
- Pain Medicine 14
- Endocrinology & Diabetes 14
- Physical Medicine & Rehabilitation (PM&R) 13
- Ophthalmology 13
- Infectious Disease 12
- Rheumatology 11
- ENT (Otolaryngology) 11
- Transplant Surgery 10
- Cardiothoracic Surgery 8
- Heart Failure & Transplant Cardiology 7
- Psychiatry 6
- Urogynecology 6
- Surgical Oncology 6
- Interventional Cardiology 5
- Plastic Surgery 5
- Sports Medicine 4
- OB-GYN (Obstetrics & Gynecology) 4
- Colorectal Surgery 4
- Allergy & Immunology 4
- Hospice & Palliative Medicine 4
- Dermatopathology 3
- Vascular Surgery 3
- Cardiac Electrophysiology 3
- Sleep Medicine 2
- Medical Oncology 2
- Gynecologic Oncology 2
- Hand Surgery 2
- Hematology 2
- Mohs Surgery 2
- Obesity Medicine 1
- Neuroradiology 1
- Trauma Surgery 1
- Medical Genetics 1
- Hepatology 1
- Nuclear Medicine 1
Other clinicians
Medical groups whose clinicians work here
- Mayo Clinic Jacksonville 1,411
- Ability Health Services and Rehabilitation LP 27
- Ability Health Services, Inc 27
- Physical Medicine Specialists, Inc 19
- University of Florida Jacksonville Physicians, Inc. 18
- Florida Rehab Specialists, PLLC 5
- First Coast Surgical Associates Inc. 5
- Vip Specialties of Florida 4
- North Florida Anesthesia Consultants Inc 4
- Ibrahim Heart Clinic PLLC 4
- Symphony Specialty Group, LLC 3
- Baptist MD Anderson Cancer Physicians Inc 3
- Jax Anesthesia Providers LLC 3
- Oceanview Medicine, PLLC 3
- Respiratory Critical Care and Sleep Medicine Associates,inc 3
Number of each group’s clinicians who list this hospital.
Industry-funded research here
Drug and device companies reported $2,029,046 in research payments to this hospital in 2025 for 53 studies.
- A randomized doubleblind phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for metastatic HER2 breast cancer HER2CLIMB05
Pfizer Inc. · $516,783 - OCS-LIVER-OLP-II
Transmedics, Inc. · $202,050 - An Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals Corporation · $157,757 - An open-label, multicenter, dose escalation and expansion phase 1,2 study to evaluate the safety, tolerability and pharmacokinetics, and anti-tumor activity of GI-102, a CD80-IgG4 Fc-IL-2v bispecific fusion protein, a…
Merck Sharp & Dohme LLC · $124,200 - A Randomized, Double-blind, Placebo-controlled Phase III Multi-center Study of Azacitidine With or Without MBG453 for the Treatment of Patients With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) …
Novartis Pharmaceuticals Corporation · $106,420 - Study name not reported
Sanofi-aventis U.S. LLC · $79,867 - CR09-005 EQUINOXE PMCF
Exactech, Inc. · $72,665 - Is Ankle Arthroscopy Safer with the Nanoscope?
Arthrex, Inc. · $64,158 - A Phase 0/Ia study of BI 907828 (Brigimadlin) concentrations in brain tissue and a non-randomized open-label, dose escalation study of BI 907828 (Brigimadlin) in combination with radiotherapy in patients with newly di…
Boehringer Ingelheim Pharmaceuticals, Inc. · $51,558 - A randomized, double-blind, parallel group, placebo-controlled, multicenter phase 3 trial to evaluate the efficacy, safety and tolerability of ianalumab on top of standard-of-care therapy in patients with active lupus
Novartis Pharmaceuticals Corporation · $49,197 - XVIVO Registry
Xvivo Perfusion Inc. · $48,000 - The EPIPHANY Study: Leveraging Pharmacogenomics in Asthma for Prediction, Mechanism and Endotyping
Genzyme Corporation · $47,920
From CMS Open Payments research payments to this hospital as a teaching hospital. Payments to affiliated universities or research foundations are reported under those names. All industry-funded trials →
Other hospitals in the same county
Sources: CMS Hospital General Information and Doctors and Clinicians Facility Affiliation (Care Compare), CMS certification number 100151. Counts are clinicians who list this hospital with Medicare; they include part-time and visiting clinicians and aren’t staff totals. Residents and beds are from the hospital’s Medicare cost report. Ratings are Medicare’s, not ours.